GRTX (OTC)
GALERA THERAPEUTICS INC
$0.085700
+0.000700 (+0.82%)
Prev close: $0.085000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- John Mel Sorensen
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $17.43M
- Employees
- 3
- P/E (TTM)
- 0.04
- P/B (TTM)
- 1.29
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.28 | $-0.41 | +0.1253 | +30.92% |
|
Jun 2023 (Q2)
|
$-0.48 | $-0.39 | -0.0941 | -24.38% |
|
Mar 2023 (Q1)
|
$-0.50 | $-0.39 | -0.1101 | -28.24% |
|
Mar 2022 (Q4)
|
$-0.58 | $-0.55 | -0.0321 | -5.86% |
Financial Statements
| Research and Development | $271.00K |
| Operating Income/Loss | -$2.23M |
| Income/Loss From Continuing Operations After Tax | $149.04M |
| Income/Loss From Continuing Operations Before Tax | $149.04M |
| Interest Expense, Operating | $0.00 |
| Net Income/Loss | $149.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $149.04M |
| Net Income/Loss Available To Common Stockholders, Basic | $62.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $86.11M |
| Preferred Stock Dividends And Other Adjustments | $86.11M |
| Basic Earnings Per Share | $0.64 |
| Diluted Earnings Per Share | $0.64 |
| Basic Average Shares | 98,503,430 |
| Diluted Average Shares | 98,503,430 |
| Assets | $6.16M |
| Current Assets | $6.06M |
| Noncurrent Assets | $101.00K |
| Liabilities | $1.14M |
| Current Liabilities | $1.14M |
| Accounts Payable | $699.00K |
| Other Current Liabilities | $442.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $728.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $728.00K |
| Liabilities And Equity | $6.16M |
| Net Cash Flow From Operating Activities | -$4.69M |
| Net Cash Flow From Operating Activities, Continuing | -$4.69M |
| Net Cash Flow From Financing Activities | $0.00 |
| Net Cash Flow | -$2.79M |
| Net Cash Flow, Continuing | -$2.79M |
| Comprehensive Income/Loss | $149.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $149.04M |
| Other Comprehensive Income/Loss | $0.00 |